Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#31 / 200 Total
SCNI - Scinai Immunotherapeutics Ltd ADR - Stock Price Chart
TickerSCNI [NASD]
CompanyScinai Immunotherapeutics Ltd ADR
CountryIsrael
IndustryBiotechnology
Market Cap2.35MEPS (ttm)-13.76
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y46.35%
P/S-EPS next 5Y-
P/B-EPS Q/Q59.70%
Dividend-Sales Q/Q-
Insider Own2.25%Inst Own7.59%
Insider Trans0.00%Inst Trans-65.24%
Short Float8.37%EarningsJul 02/b
Analyst Recom1.00Target Price700.00
Avg Volume1.06M52W Range2.23 - 14.20
Jul-23-24 07:00AM Scinai Immunotherapeutics Announces Positive Regulatory Feedback from the PEI on the path for Phase 1/2a in Plaque Psoriasis with its anti-IL-17 nanoAb (PR Newswire)
Jul-15-24 12:41PM PLUG Stock Alert: Plug Power Gets Approval for HyVia Acquisition (InvestorPlace) +45.07%
12:22PM M Stock Plunges 13% as Macy's Calls Off Take-Private Talks (InvestorPlace)
12:04PM Why Is Scinai Immunotherapeutics (SCNI) Stock Up 56% Today? (InvestorPlace)
07:00AM Scinai Immunotherapeutics Announces promising results in an in-vivo proof-of-concept psoriatic human skin model (PR Newswire)
Jul-08-24 08:14AM Scinai Immunotherapeutics Announces Receipt of an Updated Letter of Intent from the European Investment Bank Providing Specific Terms for Conversion of its Loan to Equity (PR Newswire)
Jul-03-24 09:32AM Scinai Immunotherapeutics Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements (PR Newswire)
Jul-02-24 01:52PM SCNI Stock Earnings: Scinai Immunotherapeutics Reported Results for Q1 2024 (InvestorPlace)
08:12AM Scinai Publishes Q1 2024 Financial Results and Provides Business Update (PR Newswire)
Jun-21-24 07:52AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace) -8.16%
LUMO - Lumos Pharma Inc - Stock Price Chart
TickerLUMO [NASD]
CompanyLumos Pharma Inc
CountryUSA
IndustryBiotechnology
Market Cap14.62MEPS (ttm)-4.59
P/E-EPS this Y31.82%
Forward P/E-EPS next Y36.37%
PEG-EPS past 5Y20.27%
P/S9.62EPS next 5Y15.20%
P/B0.84EPS Q/Q-44.50%
Dividend-Sales Q/Q-76.12%
Insider Own36.09%Inst Own25.90%
Insider Trans-0.09%Inst Trans7.76%
Short Float6.97%EarningsAug 01/a
Analyst Recom1.00Target Price18.00
Avg Volume34.64K52W Range1.37 - 4.55
Jul-23-24 04:05PM Lumos Pharma to Report Second Quarter 2024 Financial Results and Provide Clinical Update on August 1, 2024 (GlobeNewswire)
Jun-04-24 09:00AM Lumos Pharma Announces New Analyses of Phase 2 OraGrowtH212 Trial Presented at ENDO 2024 (GlobeNewswire)
May-20-24 04:05PM Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024 (GlobeNewswire)
May-16-24 03:02AM Lumos Pharma Inc (LUMO) Q1 2024 Earnings Call Transcript Highlights: Navigating Financial ... (GuruFocus.com) +17.41%
May-14-24 10:53PM LUMO Stock Earnings: Lumos Pharma Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace) -11.30% -12.16%
04:15PM Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-09-24 02:51PM Lumos Pharma to Report First Quarter 2024 Financial Results and Provide Clinical Update on May 15, 2024 (GlobeNewswire)
Apr-18-24 04:05PM Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings (GlobeNewswire)
Mar-20-24 08:00AM Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042 (GlobeNewswire) +7.33%
Mar-08-24 02:06PM Lumos Pharma, Inc. (NASDAQ:LUMO) Q4 2023 Earnings Call Transcript (Insider Monkey)
AMBI - Ambipar Emergency Response - Stock Price Chart
TickerAMBI [AMEX]
CompanyAmbipar Emergency Response
CountryBrazil
IndustryWaste Management
Market Cap256.09MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.17EPS Q/Q33512.70%
Dividend-Sales Q/Q-
Insider Own97.00%Inst Own1.96%
Insider Trans0.00%Inst Trans-79.68%
Short Float0.05%Earnings-
Analyst Recom-Target Price-
Avg Volume11.21K52W Range3.07 - 11.50
POAI - Predictive Oncology Inc - Stock Price Chart
TickerPOAI [NASD]
CompanyPredictive Oncology Inc
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap5.66MEPS (ttm)-3.66
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y53.33%
P/S2.89EPS next 5Y-
P/B1.38EPS Q/Q-20.41%
Dividend-Sales Q/Q74.93%
Insider Own3.69%Inst Own5.55%
Insider Trans0.00%Inst Trans-16.14%
Short Float0.48%EarningsMay 15/b
Analyst Recom1.00Target Price100.00
Avg Volume4.42M52W Range0.89 - 5.94
Today 08:00AM Predictive Oncology Announces Exercise of Warrants for $1.26 Million Gross Proceeds (GlobeNewswire) -26.20%
Jul-25-24 07:00AM Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results (GlobeNewswire) +74.77%
Jun-28-24 06:00AM 7 F-Rated Growth Stocks to Avoid Right Now: June 2024 (InvestorPlace)
Jun-11-24 08:00AM Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs) (GlobeNewswire) +8.94%
Jun-04-24 08:42AM Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery (GlobeNewswire)
May-29-24 07:00AM Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024 (GlobeNewswire) -7.43%
May-28-24 07:00AM Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire) +32.84%
May-15-24 09:52AM POAI Stock Earnings: Predictive Oncology Reported Results for Q1 2024 (InvestorPlace)
07:00AM Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
May-10-24 07:00AM Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024 (GlobeNewswire) -7.39%
CREV - Carbon Revolution Public Ltd. Co. - Stock Price Chart
TickerCREV [NASD]
CompanyCarbon Revolution Public Ltd. Co.
CountryIreland
IndustryAuto Parts
Market Cap17.10MEPS (ttm)0.02
P/E433.01EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.79EPS Q/Q-80.46%
Dividend-Sales Q/Q-
Insider Own7.11%Inst Own1.91%
Insider Trans0.00%Inst Trans-
Short Float0.11%EarningsMay 29
Analyst Recom1.00Target Price39.00
Avg Volume16.16K52W Range5.25 - 197.99
Today 07:36AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace) +46.68%
Jul-25-24 09:10PM Carbon Revolution Supplies Carbon Fiber Wheels For Chevrolet Corvette ZR1 (GlobeNewswire)
Jul-11-24 06:30AM Carbon Revolution Secures Further Release of $5 Million from OIC as Company Hits Financing Milestones (GlobeNewswire)
Jun-24-24 09:20AM Carbon Revolution Secures $25 Million Financing Agreement with OIC to Fund Growth (GlobeNewswire)
Jun-04-24 06:30AM Carbon Revolution Appoints Industry Veteran Alia Comai as Chief Revenue Officer to Lead the Sales and Strategic Partnerships (GlobeNewswire) -5.76%
May-24-24 05:25PM Carbon Revolution Secures Further Release of $5 Million from OIC and is in Ongoing Negotiations with OIC for Further Releases (GlobeNewswire) -7.56%
May-10-24 07:30AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace) +5.18%
Apr-30-24 08:45AM Carbon Revolution Wins Automotive News PACE Awards (GlobeNewswire)
Apr-26-24 05:08PM Record Revenue & Beyond: Join Fireside with CEO of Carbon Revolution May 1 at 4PM ET (IPO-Edge.com)
Apr-17-24 08:00AM Diamond Equity Research to Host Spotlight Emerging Growth Invitational Virtual Investor Conference on April 18, 2024 (GlobeNewswire)
AMIX - Autonomix Medical Inc. - Stock Price Chart
TickerAMIX [NASD]
CompanyAutonomix Medical Inc.
CountryUSA
IndustryMedical Devices
Market Cap24.24MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B3.19EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own56.40%Inst Own0.18%
Insider Trans0.00%Inst Trans-
Short Float1.40%Earnings-
Analyst Recom-Target Price-
Avg Volume4.59M52W Range0.51 - 7.60
Jul-24-24 08:00AM Autonomix Completes Licensing Transaction for FDA-Cleared Ablation Technology (GlobeNewswire)
Jul-22-24 09:05AM Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series (GlobeNewswire) +9.22%
Jul-18-24 08:30AM Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor What This Means Segment Covering Technology License Agreement (GlobeNewswire) +10.66%
Jul-16-24 08:25AM Why Is Autonomix Medical (AMIX) Stock Down 17% Today? (InvestorPlace) -23.19%
07:43AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
Jul-15-24 01:48PM Why Is Autonomix Medical (AMIX) Stock Up 120% Today? (InvestorPlace) +123.30%
01:30PM Autonomix's Trial Results Show Meaningful Reduction In Pain For Patients Suffering From Pancreatic Cancer (ACCESSWIRE)
08:00AM Autonomix Enters into Definitive Agreement to License Intellectual Property for FDA-Cleared Ablation Technology from RF Innovations, Inc. (GlobeNewswire)
Jul-12-24 08:45AM Autonomix's Trial Results Show Meaningful Reduction In Pain For Patients Suffering From Pancreatic Cancer (News Direct) +6.55%
Jul-11-24 09:00AM Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Launch of CEO Corner Platform (GlobeNewswire) +7.21%
AEYE - AudioEye Inc - Stock Price Chart
TickerAEYE [NASD, RUT]
CompanyAudioEye Inc
CountryUSA
IndustrySoftware - Application
Market Cap316.57MEPS (ttm)-0.29
P/E-EPS this Y333.33%
Forward P/E46.02EPS next Y23.78%
PEG-EPS past 5Y7.48%
P/S9.81EPS next 5Y-
P/B66.01EPS Q/Q62.64%
Dividend-Sales Q/Q8.09%
Insider Own50.47%Inst Own10.85%
Insider Trans0.00%Inst Trans-2.78%
Short Float15.50%EarningsJul 25/a
Analyst Recom1.00Target Price25.75
Avg Volume272.13K52W Range3.75 - 26.16
Today 08:30AM Do Options Traders Know Something About AudioEye (AEYE) Stock We Don't? (Zacks) +38.24%
Jul-25-24 05:35PM AudioEye (AEYE) Tops Q2 Earnings and Revenue Estimates (Zacks)
04:36PM AudioEye: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM AudioEye Reports Record Second Quarter 2024 Results (PR Newswire)
Jul-23-24 11:39AM AudioEye (AEYE) to Report Q2 Earnings: What's in the Cards? (Zacks)
Jul-18-24 10:01AM AudioEye (AEYE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Jul-16-24 06:15PM AudioEye (AEYE) Stock Dips While Market Gains: Key Facts (Zacks) -7.66%
10:00AM Gateway Group Announces Preliminary Sponsors and Additional Presenting Companies for September Gateway Conference (GlobeNewswire)
08:30AM AudioEye Unveils AudioEyeQ Learning Platform to Provide Free Accessibility Education (PR Newswire)
Jul-09-24 06:15PM AudioEye (AEYE) Gains But Lags Market: What You Should Know (Zacks) -5.86%
KORE - Kore Group Holdings Inc - Stock Price Chart
TickerKORE [NYSE]
CompanyKore Group Holdings Inc
CountryUSA
IndustryTelecom Services
Market Cap55.24MEPS (ttm)-9.83
P/E-EPS this Y71.89%
Forward P/E-EPS next Y20.71%
PEG-EPS past 5Y-
P/S0.19EPS next 5Y-
P/B2.47EPS Q/Q23.35%
Dividend-Sales Q/Q15.16%
Insider Own69.06%Inst Own23.24%
Insider Trans-0.08%Inst Trans-
Short Float0.99%EarningsMay 15/a
Analyst Recom1.80Target Price14.50
Avg Volume50.04K52W Range1.30 - 6.55
Jul-17-24 08:00AM KORE Receives 2024 IoT Evolution Product of the Year Award (PR Newswire)
Jul-08-24 08:00AM KORE Announces Appointment of Bruce Gordon as Executive Vice President and Chief Operating Officer (PR Newswire) -11.61%
Jul-05-24 08:00AM KORE Helps mCare Digital Launch the Next Generation of Personal Emergency Technology (PR Newswire)
Jul-02-24 07:53AM KORE Stock Earnings: Kore Group Holdings Misses EPS, Misses Revenue for Q2 2023 (InvestorPlace)
Jun-21-24 06:27PM KORE to Effect a Reverse Stock Split (PR Newswire) -19.18%
Jun-18-24 08:00AM KORE Honored by Cradlepoint as Enterprise Partner of the Year (PR Newswire) -12.48%
May-15-24 09:54PM KORE Stock Earnings: Kore Group Holdings Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:30PM KORE Reports First Quarter 2024 Results (PR Newswire)
May-09-24 08:00AM KORE to Report First Quarter 2024 Results on May 15, 2024 (PR Newswire)
Apr-29-24 10:00AM KORE Announces President and CEO Transition (PR Newswire) -6.35%
SLRX - Salarius Pharmaceuticals Inc - Stock Price Chart
TickerSLRX [NASD]
CompanySalarius Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap1.91MEPS (ttm)-21.72
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y64.97%
P/S-EPS next 5Y-
P/B0.47EPS Q/Q81.69%
Dividend-Sales Q/Q-
Insider Own6.08%Inst Own4.03%
Insider Trans0.00%Inst Trans-21.08%
Short Float10.70%EarningsMay 09
Analyst Recom3.00Target Price26.00
Avg Volume1.95M52W Range1.35 - 7.92
Jul-11-24 07:29AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace) -20.51%
Jun-17-24 08:00AM Clinical Data on Salarius Pharmaceuticals' Seclidemstat in Patients with MDS and CMML Presented at the 2024 European Hematology Association Annual Meeting (GlobeNewswire)
Jun-12-24 08:00AM Salarius Pharmaceuticals Announces 1-for-8 Reverse Stock Split (GlobeNewswire)
May-13-24 10:53PM SLRX Stock Earnings: Salarius Pharmaceuticals Beats EPS for Q1 2024 (InvestorPlace) -7.12%
04:43PM Salarius: Q1 Earnings Snapshot (Associated Press Finance)
Mar-22-24 09:52PM SLRX Stock Earnings: Salarius Pharmaceuticals Beats EPS for Q4 2023 (InvestorPlace) +5.96% -17.74%
04:34PM Salarius: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM Salarius Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Feb-22-24 08:00AM Salarius Provides Update on Strategic Review Process and Plans to Support Ongoing Seclidemstat Clinical Trials by Further Reducing Expenses (GlobeNewswire)
Jan-16-24 08:00AM Salarius Pharmaceuticals Issued U.S. Patent for Next-Generation Targeted Protein Degraders (GlobeNewswire)
NWL - Newell Brands Inc - Stock Price Chart
TickerNWL [NASD]
CompanyNewell Brands Inc
CountryUSA
IndustryHousehold & Personal Products
Market Cap3.70BEPS (ttm)-0.71
P/E-EPS this Y-23.45%
Forward P/E11.68EPS next Y26.19%
PEG-EPS past 5Y43.59%
P/S0.46EPS next 5Y6.70%
P/B1.20EPS Q/Q91.19%
Dividend3.24%Sales Q/Q-8.42%
Insider Own0.39%Inst Own98.20%
Insider Trans-4.14%Inst Trans1.03%
Short Float5.77%EarningsJul 26/b
Analyst Recom2.79Target Price7.70
Avg Volume4.32M52W Range5.39 - 11.61
Today 05:40PM Crock-Pot Parent Newell's Stock Leaps Back Into the Green (Investopedia) +40.54%
04:21PM Newell Brands stock surges on Q2 earnings beat, raised guidance (Yahoo Finance Video)
12:56PM Newell's (NWL) Q2 Earnings Beat Mark, Soft Core Sales Hurt (Zacks)
12:27PM Newell Brands, 3M rise; Saia, DexCom fall, Friday, 7/26/2024 (Associated Press)
09:30AM Compared to Estimates, Newell Brands (NWL) Q2 Earnings: A Look at Key Metrics (Zacks)
08:15AM Newell Brands (NWL) Q2 Earnings Beat Estimates (Zacks)
07:11AM Newell Brands: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM Newell Brands Announces Second Quarter 2024 Results (Business Wire)
Jul-24-24 08:01AM Sharpie is Giving Away Half a Million Markers to Inspire the Next Generation of Creativity (PR Newswire)
Jul-22-24 09:32AM Newell (NWL) Gears Up for Q2 Earnings: What You Should Know (Zacks)
12345678910⋯20
affiliate • advertise • toggle light mode • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.